查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825831

2025年无针给药装置全球市场报告

Needle-Free Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

无针给药设备市场预计将在未来几年快速成长，到 2029 年将达到 276.8 亿美元，复合年增长率为 10.5%。预测期内的增长可归因于对无痛给药的需求不断增长、对以患者为中心的医疗保健解决方案的日益重视、在儿科和老年人群中的应用不断扩大、需要频繁注射的慢性病患病率上升、提高设备效率和易用性的技术进步、扩大新兴市场的医疗保健可及性，以及对创新给药系统研发的投资不断增加。预测期内的主要趋势包括穿戴式和连网型设备的日益普及、新型微流体技术的出现、对儿科友善无针解决方案的日益关注、人工智慧和机器学习演算法的整合以及在家庭医疗保健环境中的应用不断扩大。

未来五年的预测成长率为10.5%，较我们先前对该市场的预测略有下降0.9%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致英国和韩国研发的喷射注射器和微针贴片价格上涨，阻碍无痛疫苗在美国的广泛普及，导致疫苗接种率下降和儿科医疗费用上升。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，其影响可能更为广泛。

糖尿病盛行率的不断上升预计将在未来几年推动无针给药装置市场的扩张。糖尿病是一种慢性疾病，其特征是血糖值升高，由胰岛素分泌不足或无法有效使用胰岛素所引起。糖尿病盛行率的上升归因于久坐不动的生活方式、不良饮食、遗传因素、都市化、老化、医疗保健机会有限以及全球肥胖率上升等因素。无针给药装置已成为糖尿病管理中传统胰岛素注射的替代品。这些装置，包括喷射注射器和经皮吸收贴片，无需针头透过皮肤注射胰岛素，减少了注射带来的不适和焦虑，提高了使用者的舒适度。例如，2024年6月，英国国家医疗服务体系（NHS）报告称，2023年，英格兰将有超过50万人（54.9万人）面临患2型糖尿病的风险，这使得在全科医生处登记的非糖尿病性高血糖症（糖尿病前期）患者总数达到3,615,330人。这比2022年的3,065,825人增加了近20%，凸显了糖尿病盛行率的上升。因此，糖尿病盛行率的上升正在推动无针给药设备市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球无针给药装置：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球无针给药装置市场：成长率分析
  • 全球无针给药设备市场表现：规模与成长，2019-2024
  • 全球无针给药装置市场预测：规模与成长，2024-2029年，2034年
  • 全球无针给药装置：总目标市场（TAM）

第六章 市场细分

  • 全球无针给药设备市场（按设备类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 吸入器
  • 喷射器
  • 新针
  • 经皮吸收贴片
  • 其他的
  • 全球无针给药设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 疼痛管理
  • 疫苗递送
  • 小儿注射
  • 胰岛素注射
  • 其他的
  • 全球无针给药设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 家庭医疗保健
  • 全球无针给药设备市场：吸入器细分、类型、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器（DPI）
  • 定量喷雾吸入器（MDI）
  • 喷雾器
  • 全球无针给药装置市场：喷射器细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 高压喷射器
  • 弹簧喷射器
  • 电池供电喷射器
  • 全球无针给药装置市场：新型针头细分市场、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 微针阵列
  • 奈米针阵列
  • 全球无针给药设备市场：经皮吸收贴片细分市场、类型、效能及预测（2019-2024、2024-2029、2034）
  • 微针贴片
  • 传统贴片（尼古丁、荷尔蒙、止痛药）
  • 全球无针给药装置市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 口服给药装置
  • 植入式药物传输系统
  • 舌下给药装置

第七章 区域和国家分析

  • 全球无针给药装置市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球无针给药设备市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 无针给药装置市场：竞争格局
  • 无针给药装置市场：公司简介
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Bayer AG
    • 3M Company
    • Medtronic plc

第31章：其他领先和创新企业

  • Novo Nordisk AS
  • Becton, Dickinson and Company
  • Endo International plc
  • Insulet Corporation
  • Purdue Pharma LP
  • Antares Pharma Inc.
  • MannKind Corporation
  • Med-Jet Inc.
  • Portal Instruments
  • PharmaJet
  • Inovio Pharmaceuticals, Inc.
  • National Medical Products Inc.
  • Mika Medical Co. Ltd.
  • Medical International Technology Inc.（MTI）
  • NanoPass Technologies Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年无针给药装置市场：提供新机会的国家
  • 无针给药设备市场，2029年：细分市场带来新机会
  • 2029年无针给药设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30775u

Needle-free drug delivery devices are medical tools designed to administer medication without the use of traditional needles. They provide an alternative method for delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes, aiming to reduce patient discomfort and the risk of needle-related injuries.

The primary types of needle-free drug delivery devices include inhalers, jet injectors, novel needles, transdermal patches, and others. Inhalers are portable devices that deliver medication directly into the lungs through a mist or spray. They find applications in various areas such as pain management, vaccine delivery, pediatric injections, insulin delivery, among others, and are utilized by a range of end-users including hospitals and clinics, as well as home healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The needle-free drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides needle-free drug delivery devices market statistics, including needle-free drug delivery devices industry global market size, regional shares, competitors with a needle-free drug delivery devices market share, detailed needle-free drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the needle-free drug delivery devices industry. This needle-free drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The needle-free drug delivery devices market size has grown rapidly in recent years. It will grow from $16.7 billion in 2024 to $18.54 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for painless drug delivery methods, high geriatric population, emphasis on patient compliance and safety, regulatory support for needle-free technologies, and expanded pharmaceutical industry.

The needle-free drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $27.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for painless medication administration, growing emphasis on patient-centric healthcare solutions, expanding applications in pediatric and geriatric populations, rising prevalence of chronic diseases necessitating frequent injections, technological advancements enhancing device efficiency and usability, expanding access to healthcare in emerging markets, and growing investments in research and development for innovative delivery systems. Major trends in the forecast period include increased adoption of wearable and connected devices, the emergence of novel microfluidic technologies, a growing focus on pediatric-friendly needle-free solutions, the integration of artificial intelligence and machine learning algorithms, and expanding applications in home healthcare settings.

The forecast of 10.5% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of painless vaccination by inflating prices of jet injectors and microneedle patches developed in the UK and South Korea, resulting in reduced immunization rates and higher pediatric care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the needle-free drug delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels, resulting from insufficient insulin production or the body's inability to effectively use insulin. The rise in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, genetic factors, urbanization, aging populations, limited healthcare access, and increasing obesity rates globally. Needle-free drug delivery devices offer an alternative to traditional insulin injections in diabetes management. These devices, including jet injectors and transdermal patches, administer insulin through the skin without the need for needles, reducing the discomfort and anxiety associated with injections while improving user comfort. For instance, in June 2024, the UK's National Health Service reported that in 2023, over half a million (549,000) more individuals in England were found to be at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents an increase of nearly 20% from 3,065,825 in 2022, highlighting the growing incidence of diabetes. Consequently, the rising prevalence of diabetes is fueling the growth of the needle-free drug delivery device market.

Prominent companies in the needle-free drug delivery device market are concentrating on innovative solutions such as dual-chamber inhalers to enhance effectiveness and ease of administration, addressing the evolving needs of patients and healthcare providers. A dual-chamber inhaler comprises two compartments capable of holding different medications separately, facilitating the combination of multiple drugs in a single device for streamlined treatment and enhanced patient convenience. For instance, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler in April 2024, a state-of-the-art dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. Equipped with a dose counter, this dual-chamber inhaler ensures precise medication administration and features an all-plastic construction devoid of metal parts, ideal for complex inhalation treatments. Advanced functionalities such as a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals indicating proper usage, enhance user experience. The integrated dose counter facilitates accurate monitoring of medication usage, minimizing dosage errors.

In May 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million, aiming to strengthen its position as a leading drug delivery company. Leveraging Antares' auto-injector platform and specialty commercial business, Halozyme expands its strategy to include specialty products, accelerating long-term revenue growth. Antares Pharma Inc., a US-based pharmaceutical company, specializes in developing needle-free injectors used for insulin delivery in diabetes treatment.

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the needle-free drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The needle-free drug delivery devices market consists of sales of nasal sprays, buccal patches, and oral inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Needle-Free Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on needle-free drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for needle-free drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The needle-free drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
  • 2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
  • 3) By End-User: Hospitals And Clinics; Home Healthcare
  • Subsegments:
  • 1) By Inhalers: Dry Powder Inhalers (Dpi); Metered Dose Inhalers (Mdi); Nebulizers
  • 2) By Jet Injectors: High-Pressure Jet Injectors; Spring-Powered Jet Injectors; Battery-Operated Jet Injectors
  • 3) By Novel Needles: Micro-Needle Arrays; Nano-Needle Arrays
  • 4) By Transdermal Patches: Microneedle Patches; Conventional Patches ( Nicotine, Hormonal, Pain Relief)
  • 5) By Other Device Types: Oral Drug Delivery Devices; Implantable Drug Delivery Systems; Sublingual Drug Delivery Devices
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; 3M Company; Medtronic plc; Novo Nordisk AS; Becton, Dickinson and Company; Endo International plc; Insulet Corporation; Purdue Pharma L.P.; Antares Pharma Inc.; MannKind Corporation; Med-Jet Inc.; Portal Instruments; PharmaJet; Inovio Pharmaceuticals, Inc.; National Medical Products Inc.; Mika Medical Co. Ltd.; Medical International Technology Inc. (MTI); NanoPass Technologies Ltd.; PenJet Corporation; Akra Dermojet S.A.; NuGen Medical Devices Inc.; Crossject SA; Injex Pharma AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Needle-Free Drug Delivery Devices Market Characteristics

3. Needle-Free Drug Delivery Devices Market Trends And Strategies

4. Needle-Free Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Needle-Free Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Needle-Free Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Needle-Free Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Needle-Free Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Needle-Free Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Needle-Free Drug Delivery Devices Total Addressable Market (TAM)

6. Needle-Free Drug Delivery Devices Market Segmentation

  • 6.1. Global Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inhalers
  • Jet Injectors
  • Novel Needles
  • Transdermal Patches
  • Other Device Types
  • 6.2. Global Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Vaccine Delivery
  • Pediatric Injections
  • Insulin Delivery
  • Other Applications
  • 6.3. Global Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare
  • 6.4. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers (DPI)
  • Metered Dose Inhalers (MDI)
  • Nebulizers
  • 6.5. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Pressure Jet Injectors
  • Spring-Powered Jet Injectors
  • Battery-Operated Jet Injectors
  • 6.6. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Novel Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Micro-Needle Arrays
  • Nano-Needle Arrays
  • 6.7. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Transdermal Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microneedle Patches
  • Conventional Patches (Nicotine, Hormonal, Pain Relief)
  • 6.8. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Drug Delivery Devices
  • Implantable Drug Delivery Systems
  • Sublingual Drug Delivery Devices

7. Needle-Free Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Needle-Free Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Needle-Free Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Needle-Free Drug Delivery Devices Market

  • 8.1. Asia-Pacific Needle-Free Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Needle-Free Drug Delivery Devices Market

  • 9.1. China Needle-Free Drug Delivery Devices Market Overview
  • 9.2. China Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Needle-Free Drug Delivery Devices Market

  • 10.1. India Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Needle-Free Drug Delivery Devices Market

  • 11.1. Japan Needle-Free Drug Delivery Devices Market Overview
  • 11.2. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Needle-Free Drug Delivery Devices Market

  • 12.1. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Needle-Free Drug Delivery Devices Market

  • 13.1. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Needle-Free Drug Delivery Devices Market

  • 14.1. South Korea Needle-Free Drug Delivery Devices Market Overview
  • 14.2. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Needle-Free Drug Delivery Devices Market

  • 15.1. Western Europe Needle-Free Drug Delivery Devices Market Overview
  • 15.2. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Needle-Free Drug Delivery Devices Market

  • 16.1. UK Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Needle-Free Drug Delivery Devices Market

  • 17.1. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Needle-Free Drug Delivery Devices Market

  • 18.1. France Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Needle-Free Drug Delivery Devices Market

  • 19.1. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Needle-Free Drug Delivery Devices Market

  • 20.1. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Needle-Free Drug Delivery Devices Market

  • 21.1. Eastern Europe Needle-Free Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Needle-Free Drug Delivery Devices Market

  • 22.1. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Needle-Free Drug Delivery Devices Market

  • 23.1. North America Needle-Free Drug Delivery Devices Market Overview
  • 23.2. North America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Needle-Free Drug Delivery Devices Market

  • 24.1. USA Needle-Free Drug Delivery Devices Market Overview
  • 24.2. USA Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Needle-Free Drug Delivery Devices Market

  • 25.1. Canada Needle-Free Drug Delivery Devices Market Overview
  • 25.2. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Needle-Free Drug Delivery Devices Market

  • 26.1. South America Needle-Free Drug Delivery Devices Market Overview
  • 26.2. South America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Needle-Free Drug Delivery Devices Market

  • 27.1. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Needle-Free Drug Delivery Devices Market

  • 28.1. Middle East Needle-Free Drug Delivery Devices Market Overview
  • 28.2. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Needle-Free Drug Delivery Devices Market

  • 29.1. Africa Needle-Free Drug Delivery Devices Market Overview
  • 29.2. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Needle-Free Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Needle-Free Drug Delivery Devices Market Competitive Landscape
  • 30.2. Needle-Free Drug Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Needle-Free Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk AS
  • 31.2. Becton, Dickinson and Company
  • 31.3. Endo International plc
  • 31.4. Insulet Corporation
  • 31.5. Purdue Pharma L.P.
  • 31.6. Antares Pharma Inc.
  • 31.7. MannKind Corporation
  • 31.8. Med-Jet Inc.
  • 31.9. Portal Instruments
  • 31.10. PharmaJet
  • 31.11. Inovio Pharmaceuticals, Inc.
  • 31.12. National Medical Products Inc.
  • 31.13. Mika Medical Co. Ltd.
  • 31.14. Medical International Technology Inc. (MTI)
  • 31.15. NanoPass Technologies Ltd.

32. Global Needle-Free Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Needle-Free Drug Delivery Devices Market

34. Recent Developments In The Needle-Free Drug Delivery Devices Market

35. Needle-Free Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Needle-Free Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Needle-Free Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Needle-Free Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer